Skip to main content
. Author manuscript; available in PMC: 2013 Sep 15.
Published in final edited form as: Int J Pharm. 2012 May 23;434(1-2):306–314. doi: 10.1016/j.ijpharm.2012.05.028

Table. I.

Permeability values of Vandetanib across MDCK cell monolayers

Permeability (×106)cm/sec
Cell line Drug ± Inhibitor A-B B-A Efflux Ratio
MDCK-WT Vandetanib 7.57±0.52 8.08±0.17 1.06
MDCK-MDR1 Vandetanib 5.73±0.29 4.66±0.26 0.81
MDCK-Bcrp1 Vandetanib 5.66±1.26 42.32±2.64 7.5
Vandetanib+Ko143 8.58±0.63 8.58±0.69 1
Vandetanib+Everolimus 7.29±1.24 10.03±0.79 1.4
Vandetanib+Temsirolimus 10.80±1.22 11.81±0.30 1.1